123 related articles for article (PubMed ID: 32064895)
1. Discovery of candidate gene expression signatures in peripheral blood for the screening of cervical cancer.
Ma Q; Shao Y; Chen W; Quan C; Zhu Y; Xu X; Zhou Z; Wang S
Biomark Med; 2020 Feb; 14(2):109-118. PubMed ID: 32064895
[No Abstract] [Full Text] [Related]
2. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
3. Construction of a diagnostic classifier for cervical intraepithelial neoplasia and cervical cancer based on XGBoost feature selection and random forest model.
Zhang J; Yang X; Chen J; Han J; Chen X; Fan Y; Zheng H
J Obstet Gynaecol Res; 2023 Jan; 49(1):296-303. PubMed ID: 36220631
[TBL] [Abstract][Full Text] [Related]
4. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
5. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.
Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y
Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning.
Huang J; Qian Z; Gong Y; Wang Y; Guan Y; Han Y; Yi X; Huang W; Ji L; Xu J; Su M; Yuan Q; Cui S; Zhang J; Bao C; Liu W; Chen X; Zhang M; Gao X; Wu R; Zhang Y; Xu H; Zhu S; Zhu H; Yang L; Xu X; Zhou P; Liang Z
J Med Genet; 2019 Mar; 56(3):186-194. PubMed ID: 30567904
[TBL] [Abstract][Full Text] [Related]
7. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y
BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
9. Prediction of a miRNA-mRNA functional synergistic network for cervical squamous cell carcinoma.
Sun D; Han L; Cao R; Wang H; Jiang J; Deng Y; Yu X
FEBS Open Bio; 2019 Dec; 9(12):2080-2092. PubMed ID: 31642613
[TBL] [Abstract][Full Text] [Related]
10. Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer.
Espinosa AM; Alfaro A; Roman-Basaure E; Guardado-Estrada M; Palma Í; Serralde C; Medina I; Juárez E; Bermúdez M; Márquez E; Borges-Ibáñez M; Muñoz-Cortez S; Alcántara-Vázquez A; Alonso P; Curiel-Valdez J; Kofman S; Villegas N; Berumen J
PLoS One; 2013; 8(2):e55975. PubMed ID: 23405241
[TBL] [Abstract][Full Text] [Related]
11. Human telomerase RNA gene amplification detection increases the specificity of cervical intraepithelial neoplasia screening.
Zheng L; Liu AL; Qi T; Wang Q; Cai Z; Su YJ; Hu YW; Liu GB; Wei LH
Int J Gynecol Cancer; 2010 Aug; 20(6):912-7. PubMed ID: 20683395
[TBL] [Abstract][Full Text] [Related]
12. The use of micro RNA in the early detection of cervical intraepithelial neoplasia.
Wittenborn J; Weikert L; Hangarter B; Stickeler E; Maurer J
Carcinogenesis; 2020 Dec; 41(12):1781-1789. PubMed ID: 32417880
[TBL] [Abstract][Full Text] [Related]
13. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
14. Serum Immune Profiling for Early Detection of Cervical Disease.
Ewaisha R; Panicker G; Maranian P; Unger ER; Anderson KS
Theranostics; 2017; 7(16):3814-3823. PubMed ID: 29109779
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.
Liu P; Xin F; Ma CF
Genet Mol Res; 2015 Dec; 14(4):17995-8002. PubMed ID: 26782446
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of women with varying degrees of cervical intraepithelial neoplasia.
Kendrick JE; Conner MG; Huh WK
J Low Genit Tract Dis; 2007 Jan; 11(1):25-8. PubMed ID: 17194947
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X
Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350
[TBL] [Abstract][Full Text] [Related]
18. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China.
Hong D; Ye F; Chen H; Lü W; Cheng Q; Hu Y; Xie X
Int J Gynecol Cancer; 2008; 18(1):104-9. PubMed ID: 17466048
[TBL] [Abstract][Full Text] [Related]
19. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
[TBL] [Abstract][Full Text] [Related]
20. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
